This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Helmholtz-Zentrum Fur Infektionsforschung Gmbh. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Roman Sommer: Innovator in Lectin Inhibition
Introduction
Roman Sommer is a notable inventor based in Saarbruecken, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that serve as inhibitors of LecB. His work is crucial in the fight against infections, showcasing the importance of innovation in pharmaceutical research.
Latest Patents
Roman Sommer holds 1 patent related to his invention titled "Inhibitors of LecB." This patent focuses on compounds derived from deoxy fucose, which are useful as lectin inhibitors. The invention also encompasses pharmaceutical compositions that include these compounds, highlighting their therapeutic potential in preventing and treating infections.
Career Highlights
Sommer is affiliated with Helmholtz-Zentrum für Infektionsforschung GmbH, where he conducts his research. His work at this esteemed institution underscores his commitment to advancing medical science and improving health outcomes through innovative solutions.
Collaborations
Roman Sommer has collaborated with notable colleagues, including Alexander Titz. These partnerships enhance the research environment and contribute to the development of groundbreaking solutions in the field of infection research.
Conclusion
Roman Sommer's contributions to the field of lectin inhibition exemplify the vital role of inventors in advancing medical science. His innovative work continues to pave the way for new therapeutic approaches to combat infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile